Recombinant Human Plasminogen Activator
Large Vessel Occlusion
Xuanwu Hospital, BeijingN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
7 Active assets in the Large Vessel Occlusion cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Tenecteplase Xuanwu Hospital, Beijing | Phase 3 | BB |
Tirofiban Xuanwu Hospital, Beijing | Phase 3 | B |
Semaglutide Wei Hu | Phase 3 | B |
Dexborneol Beijing Tiantan Hospital | Phase 2 | CCC |
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril Beijing Tiantan Hospital | Phase 2 | CCC |
View all 9 →
Same molecule, other indications
Recombinant Human Plasminogen Activator is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →